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n this study we developed and evaluated stable, biodegradable microspheres for controlled release of 
venlafaxine. For this purpose, polycaprolactone, a hydrophobic polymer was used in different ratios. 
Following are the drug to polymer ratios P1 (1:1), P2 (1:1.5), P3 (1:2), P4 (1:2.5) and P5 (1:3); employed to 
develop controlled release microspheres. Drug loading efficiency increased with increasing quantity of 
polycaprolactone. The mechanism of venlafaxine release was studied by applying First order, Zero order, 
Higuchi’s, Hixon-Crowell and korsmeyer-Peppas models to dissolution data. Higuchi model was found the best 
fit model followed by First order release. The mechanism of release was non-Fickian diffusion. All formulations 
showed an initial burst of 69.53%, 62.37%, 55.45%, 53.76% and 49.32% from P1, P2, P3, P4 and P5 
formulations, respectively at the end of 1st h dissolution. P5 was the superior formulation in terms of reduced 
initial burst and after which sustained release occurred up to 8 hours. The developed microspheres were 
characterized by Fourier transform infra-red spectroscopy, scanning electron spectroscopy, differential 
scanning calorimetry and thermogravimetric analysis. 
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1. INTRODUCTION 
Over the past 50 years, polymeric microparticles 
have attracted a great focus in biomedical field 
particularly in drug delivery. Polycaprolactone (PCL) 
is Food & Drug Administration (FDA) approved 
slowly degrading polymer. It degrades through ester 
linkages. Many drugs have been encapsulated into 
PCL microparticles. PCL produce lesser acidic 
environment on degradation compared to poly lactic 
acid (Sinha et al., 2004; Bock et al., 2011).  
Over the past few decades, biodegradable 
microparticles have attracted a great attention in 
development of controlled release formulations (Park 
et al., 2005; Jeong et al., 1997; Hejazi et al., 2003). 
Biodegradable polymers degrade to compatible 
products either through chemical or enzymatic 
hydrolysis. Biodegradable microspheres have shown 
a promising ability for controlled release of a large 
variety of drugs regardless of low or high water 
solubility. The rate of release of drug through 
biodegradable microspheres can be controlled by 
biodegradation kinetics of polymer, physiochemical 
attributes of polymers and drugs, thermodynamic 
compatibility and shape and size of device (Jain, 
2000; Berkland et al., 2002; Sinha et al., 2003; Mi et 
al., 2002; Abraham et al., 2003; Liu et al., 2004; Chen 
et al., 2001; Tunon et al., 2003).  
Polycaprolactone is a white to off-white, 
thermoplastic, semi-crystalline, linear polyester. 
Commercially, PCL is produced by ring opening 
polymerization of lactone. It is a biodegradable 
polymer derived from petroleum products. PCL can 
be degraded and mineralized by many 
microorganisms. Melting point of PCL is 
approximately 62°C and sealing temperature is 22°C. 
PCL is finely soluble in ethyl acetate, chloroform, 
acetone, dichloro methane, toluene, dimethyl 
sulfoxide and dimethyl formamide. PCL is insoluble 
in n-hexane, isopropyl alcohol and methanol (Chitra 
et al., 2010). Synthetic polymers are versatile 
polymers that have a great number of properties to 
be used in biomedical applications. They are being 
applied in controlled drug delivery, nano particulate 
formation, macromolecular drug carriers, stabilizing 
agents, implants and diagnostic agents (Moghimi et 
al., 2001).  
 
I 
 23 
 
Biodegradable polymers are preferred choice for 
development of controlled drug delivery devices. 
Biodegradable polymers offer certain advantages like 
improving bioavailability, reducing systemic side 
effects, protecting drug molecules from biochemical 
degradation, enhance drug targeting and specificity. 
PCL possess low immunogenicity and toxicity. It 
exhibits high compatibility. Physiochemical and 
mechanical properties of PCL can be tailored to 
develop suitable drug carriers. On degradation, PCL 
does not produce acidic components. PCL is slowly 
degraded compared to that of poly lactic acid and 
poly glycolic acid which make it a suitable 
biomaterial (Enayati et al., 2010). PCL has well 
established biocompatibility profile. It is being used 
in/as controlled drug delivery, dermal filler, wound 
dressing, oral and maxillofacial surgery (Sinha et al., 
2004). PCL is a non-toxic bioresorbable polymer 
that degrades in a safe way (deMelo et al., 2012). 
Slow biodegradation of PCL produce a sustained 
release of entrapped drug for a prolonged period of 
time (Vilar et al., 2012). PCL is a semi crystalline 
synthetic polyester used extensively in medical and 
drug delivery devices. It contains aliphatic ester 
linkages susceptible to both hydrolytic and 
enzymatic degradation (Alzet et al., 2008). de la Ossa 
and coworkers prepared PCL microspheres using 
O/W solvent evaporation method. The loaded drug, 
cannabinoids was slowly released in-vitro within ten 
days (de la Ossa et al., 2012). Microencapsulation of 
water soluble drugs with conventional O/W solvent 
evaporation method causes rapid partitioning of 
drug from organic solvent to aqueous phase with no 
or little amount of drug loading. Smart modification 
of conventional method has been reported to 
overcome this problem. O/O type microspheres can 
be prepared by dissolving polymer and drug in 
organic phase and then dispersing it to immiscible 
oil phase. The elimination of aqueous phase suitably 
reduces the partitioning of water soluble drug into 
continuous phase provided that drug is immiscible 
with oil. Sturesson et al., prepared O/O based 
microspheres of timolol maleate. Poly 
lactic-co-glycolic acid (PLGA) and drug were 
dissolved in acetonitrile; sesame oil was the 
immiscible continuous phase and span 80 was used 
as emulsion stabilizer. Microspheres were separated 
by filtration and washing with n-hexane. PLGA 
microspheres showed an initial burst release, then a 
slow phase followed by secondary burst (O’Donnell 
et al., 1997; Bodmeier et al., 1987; Sturesson et al., 
1993). In this work, we make an effort to prepare 
controlled release microspheres of venlafaxine using 
different ratios of PCL. Venlafaxine is a highly water 
soluble drug having water solubility of 572 mg/ml 
(Ali et al., 2014). Simple O/O solvent evaporation 
method was applied to develop free flowing 
microparticles. The prepared microparticles were 
evaluated for percent recovery, drug entrapment 
efficiency, morphology, micromeritic properties, 
dissolution, compatibility and thermal stability.  
2. MATERIAL AND METHODS 
Polycaprolactone (Mol. Wt. 80000) and dichloro 
methane were purchased from Fluke, Buch 
Switzerland. Corn oil, n-heptane, potassium 
dihydrogen phosphate, ethanol, span 85 and 
hydrochloric acid were purchased from Biosciences, 
England. Corn oil was obtained from Cheil Jedang 
Corp., Korea. 
2.1 Preparation of Microspheres 
Venlafaxine microspheres were prepared using 
solvent evaporation method. The polymer was 
dissolved in various ratios in dichloro methane by 
stirring at 400 rpm for 0.5 h. The drug was added to 
polymer solution and dispersed for five minutes on 
ultrasonic bath. Corn oil was taken in 250 mL beaker 
along with Span 85. The dispersion containing the 
drug and polymer was slowly added drop by drop to 
250 mL beaker containing 120 mL of corn oil. The 
corn oil was stirred continuously at 600 rpm with 
magnetic stirrer for 5 h till complete evaporation of 
organic solvent. The microspheres were collected 
and washed on filter paper under vacuum filtration. 
The filtered microspheres were rinsed with small 
quantity of distilled water and washed with 
n-heptane 4-5 times in order to remove the adhered 
oil. The prepared microspheres were dried at 40°C 
in hot air oven (Memmert, Germany). The dried 
microspheres were stored in air-tight glass jars.  
2.2 Percent Recovery 
Percent product recovery of PCL microspheres was 
calculated using following mathematical relation: 
 
2.3 Encapsulation Efficiency 
Encapsulation efficiency of PCL microspheres was 
measured by dissolving accurately measured weight 
(20 mg) of P1, P2, P3, P4 and P5 microspheres in 20 
mL dichloromethane: distilled water (50:%50) and 3 
mL ethanol was added to precipitate PCL. 
Dichloromethane dissolves the PCL layer. The 
solution was filtered through Millipore and diluted 
suitably with distilled water. The filtrate was stirred 
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for one h at 40°C to remove the organic solvent. 
After evaporation of organic solvent the absorbance 
of venlafaxine was measured at 226 nm using a 
UV-VIS spectrophotometer (UV-1100, Schimadzu). 
Encapsulation efficiency of PCL microspheres was 
calculated as follows (Sivabalan et al., 2012): 
 
 
2.4 Tapped Density 
Packing properties of microparticles into capsules 
can be measured using tapped density.  Tapped 
density also influence flow and mixing properties of 
microspheres in preparation of tablets. The tapped 
density of microspheres was measured by using a 10 
mL measuring cylinder and total number of tapings 
was fixed to 100. 100 tapings are sufficient to 
achieve plateau condition. Following formula was 
used to calculate tapped density (Shariff et al., 2007).  
 
2.5 Angle of Repose 
To measure the angle of repose, microparticles were 
passed through a funnel on a flat surface. The radius 
(r) and height (h) of microparticle heap achieved 
after passing through funnel on flat surface was also 
measured. Following relation was applied to calculate 
angle of repose: 
 
2.6 Hausner’s Ratio 
Flowability microparticles can be assessed by 
calculating Hausner’s ratio. It can be calculated by 
following relation: 
 
A value of Hausner’s ratio less than 1.2 indicates 
good flow. 
2.7 Carr’s Index 
It is also called compressibility index. Carr’s index is 
an indirect measure of size, shape, cohesiveness and 
bulk density of microparticles. Following formula was 
used to measure Carr’s index: 
 
2.8 FTIR 
FTIR analysis was carried out to study the 
interactions between PCL and venlafaxine 
hydrochloride. The spectra were obtained for pure 
venlafaxine, PCL and drug-loaded microspheres. 
Midac USA 2000 FTIR instrument was used to 
record spectra. Samples were prepared using KBr 
discs. The spectra were recorded at a scanning range 
of 500-4000 cm-1 at resolution of 2 cm-1. 
2.9 Thermal Analysis 
Thermogravimetric and differential scanning 
calorimetry of pure venlafaxine, PCL and 
venlafaxine-loaded microspheres were carried out 
simultaneously using Q600 simultaneous DSC/TGA 
Analyzer, USA. Microspheres were crushed and a 
small amount (4-5 mg) was placed in aluminium 
pans and sealed for test. The sealed sampled were 
heated at a rate of 20°C per minute. All experiments 
were performed under nitrogen atmosphere at a rate 
of 25 mL per minute over the temperature range of 
25°C to 400°C. The instrument was calibrated using 
Indium. 
2.10 In-vitro Release Properties  
Measured quantity of microparticles was placed in 
dialysis bag and tied to paddle of USP dissolution 
apparatus II. Buffer of pH 7.4 was used as release 
media. The volume of release media was 900 mL and 
paddle speed was 50rpm. Temperature of release 
media was maintained at 37±1°C throughout the 
study. An aliquot of 2mL was collected at various 
time intervals and replaced with fresh equal amount 
of buffer. The aliquot was suitably diluted with 
distilled water and analyzed at 226 nm 
spectrophotometrically. The amount of drug released 
at each time interval was measured by using 
standard calibration curve. The cumulative release 
was calculated by following relation: 
 
 
Where, Ft and F∞  represent amount of drug 
released at time t and total amount of drug released 
from microspheres, respectively.  
 
2.11 Mathematical Modeling 
 
Drug release from various drug delivery devices is 
assumed to follow different mechanism and patterns. 
Mathematical modeling of release data is commonly 
performed to assess the mechanism of drug release 
from different carriers. Zero order release equation 
describes that drug release is at constant rate and is 
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independent of its concentration (Najib et al., 1985). 
First order equation explains systems where drug 
release is dependent on its concentration from a 
device (Desai et al., 1966). Hixon-Crowell equation is 
used to describe the mechanism of drug release 
depending on change of shape and size of the device 
(Hixon et al., 1931). Higuchi’s equation is based on 
drug release from insoluble matrix from insoluble 
polymeric system. It describes the time independent 
process based on Fick’s law (Higuchi, 1963). 
Korsmeyer-Peppas mathematical equation is used 
to assess the mechanism of release (Peppas, 1985).  
2.12 Size and Morphological Analysis 
Optical microscope (Nikon, Japan) was used to 
measure particle size of different PCL microspheres. 
Scanning electron microscopy was used to analyze 
the surface properties of microspheres. The 
prepared microspheres were sprinkled on one side 
of the adhesive stub. The stub was then coated with 
conductive gold with JOEL-JFC 1600 auto coater and 
was examined under JOEL-JFC 6360 SEM for 
qualitative assessment of microsphere morphology. 
3. RESULTS AND DISCUSSION 
Figure 1 (a) presents the spectrum of PCL, 
venlafaxine and PCL microspheres.  There is no 
new peak in the spectrum of drug microspheres. 
FTIR spectrum of PCL displays a characteristic 
absorption band of the carbonyl stretching mode 
around 1682 cm−1 (C=O), asymmetric stretching at 
2951 cm−1 (CH2) and symmetric stretching at 2862 
cm−1 (CH2). FTIR spectrum of venlafaxine is shown 
as Figure 1 (b), shows characteristic peak at 3330 
cm−1 due to stretching of O-H. The peak at 2825 
cm−1 is due to C-H stretch. Peak at 1208 cm−1 
indicates C-O stretching vibration. Peak of C-O-C 
stretch shoulders at 1028 cm−1. Figure 1 (c), 
displays the spectrum of venlafaxine loaded PCL 
microspheres. Analysis of spectrum reveals that 
there is no new peak.  Therefore, it can be 
concluded that PCL and venlafaxine are compatible, 
stable and no chemical interaction exists between 
them.  
Figure 1: FTIR spectra (a) PCL (b) venlafaxine (c) 
PCL microspheres 
PCL microspheres were spherical in shape and 
non-porous with smooth surfaces. Figure 2 
describes SEM micrograph of P5. The particle size of 
microspheres increased on increasing quantity of 
PCL in formulations. Mean particle size was 163 ± 
11.34, 171 ± 14.56, 189 ± 10.74, 207 ± 12.04 and 
224 ± 11.48μm for P1, P2, P3, P4 and P5, 
respectively. Increase in particle size is justified by 
the fact that a thick wall is formed on increase of 
PCL ratio. 
Figure 2: SEM micrograph of P5 
Thermal studies are performed to evaluate 
compatibility and stability of new formulations. 
Thermal studies both DSC and TGA prove some 
increase in stability of venlafaxine loaded 
biodegradable PCL microparticles and ensures 
uniform distribution of drug at molecular level. DSC 
curves of PCL, venlafaxine and venlafaxine loaded 
microspheres have been shown in Figure 3 (a), (b) 
and (c), respectively. Similarly, TGA thermograms of 
PCL, venlafaxine and PCL microparticles are shown 
in Figures 4 (a), (b) and (c), respectively. There is an 
endothermic peak at 64°C in DSC curve of PCL, 
which corresponds to melting point of PCL. The 
peaks of venlafaxine at 235°C and 268°C correspond 
to melting and degradation endotherm, respectively. 
However, these endothermic peaks were absent or 
highly reduced in intensity in DSC curve of 
venlafaxine loaded PCL microspheres. This indicated 
greater stability and compatibility due to molecular 
dispersion of venlafaxine in amorphous form in 
microspheres. The DSC technique can provide 
qualitative and quantitative information about the 
physicochemical status of drug in microspheres, 
which is reported to be involved in the endothermic 
or exothermic process. The related thermal 
transitions include melting, recrystallization, 
decomposition and out gassing or a change in heat 
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capacity. DSC is useful to monitor different samples 
of same material to assess their similarities or 
differences or the effects of additives on the thermal 
properties of a material. Using the DSC analysis of 
drug, polymer and produced microspheres, the 
nature of drug inside polymer matrix can be assessed, 
which may emerge in solid solution, metastable 
molecular dispersion or crystallization. In order to 
identify the mechanism of sustained drug release, we 
first characterized the physical state of the drug 
within the microparticles. Samples were subjected 
for DSC studies.  However, the melting peak was 
absent on the DSC thermograms of microparticles 
containing venlafaxine, indicating that the drug was 
dispersed in the microparticles as an amorphous 
form. This amorphous nature of the drug may have 
pronounced pharmaceutical significance as it could 
lead to increased solubility and finally to an 
improved biological activity (Jagadeesh et al., 2010).  
Table 1: COMPOSITION OF PCL MICROSPHERES
Formulation PCL (g) Venlafaxine (g) Corn oil (mL) Span 85 (g) 
P1 1.0 1.0 120 0.12 
P2 1.5 1.0 120 0.12 
P3 2.0 1.0 120 0.12 
P4 2.5 1.0 120 0.12 
P5 3.0 1.0 120 0.12 
Table 2: MEAN VALUES OF % YIELD AND MICROMERITIC PROPERTIES OF MICROSPHERES
Sample (%)yield Entrapment 
efficiency (%) 
Tapped 
density 
Bulk 
density 
Compressibility 
index 
Hausner’s 
ratio 
Angle 
of 
repose 
P1 91.88 64.67 0.38 0.27 11.37 1.14 25.27 
P2 92.23 63.55 0.43 0.29 11.85 1.13 26.45 
P3 91.11 69.22 0.41 0.31 10.59 1.13 25.05 
P4 90.87 71.29 0.47 0.32 12.45 1.13 27.39 
P5 92.76 70.81 0.51 0.34 13.43 1.11 27.81 
Percent recovery of PCL microspheres was >90% for 
all formulations and was independent of PCL ratio. 
However, entrapment efficiency increased gradually 
from 64.67% to 70.81 from P1 to P5. Mean values 
Figure 3: DSC curves of (a) PCL (b) venlafaxine (c) 
PCL microspheres  
of % yield and % entrapment efficiency are 
presented in Table 2. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Thermograms of (a) PCL (b) venlafaxine (c) 
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PCL microspheres 
The bulk properties of PCL microspheres have been 
presented in Table 2. All formulations of PCL 
microspheres showed good packing and free flowing 
characteristics.  
Figure 5, describes the release pattern of new 
formulations. The drug release was fast and rapid in 
formulations with less quantity of PCL. However, 
there was a gradual reduction in initial burst release 
(69.53 % from P1), (62.37 % from P2), (55.45 % 
from P3), (53.76 % from P4) and (49.32 % from P5).  
Similarly, the sustained effect was increased up to 8 
h for P5. The sudden and rapid initial release is 
attributed to high solubility of venlafaxine (572 
mg/mL). As water approaches microspheres, water 
channels are produced. Drug is leached out suddenly 
from the surface of microspheres due to its high 
solubility. The burst effect was reduced by adding 
more quantity of PCL. High amount of PCL produce 
microspheres with thick wall and large size. Water 
has to diffuse a long distance to penetrate the 
interior surface of microspheres. Thick and 
hydrophobic PCL restricts free penetration of water 
into microspheres. Regression coefficients and 
release constants were calculated by linear 
regression analysis and slope of plot area, 
respectively. The release data when fitted to various 
model equations, showed highest linearity of 
regression coefficient for Higuchi model. The release 
data was suitably explained by Higuchi’s model 
followed by first order release. The release of 
venlafaxine from insoluble, hydrophobic matrix was 
governed by time dependent diffusion based on 
Fick’s law. The mechanism of release as calculated 
from Peppas equation suggests an anomalous 
diffusion. 
 
 
 
 
 
 
 
 
 
Figure 5: Release profile of PCL microspheres 
4. Conclusion 
In this work, we developed biodegradable 
microspheres of PCL for controlled release of a novel 
highly water soluble venlafaxine. The developed 
microspheres showed good packing and flow 
properties. The structure of microsphere was 
smooth and drug entrapped was in amorphous form 
as revealed by thermal analysis. The major and 
serious drawback associated with new formulations 
was initial burst release phenomenon. However, 
burst effect was minimized to some extent by 
increasing amount of PCL in microsphere 
formulations. The burst effect was > 49 % of 
entrapped drug even with the highest quantity of 
PCL in P5. P5 showed biphasic release behaviour. 
After initial burst, the release of venlafaxine was 
sustained up to 8 h. Initial burst effect is a great 
challenge for development of controlled release 
dosage form for highly soluble venlafaxine. New 
strategies are required to overcome the burst effect. 
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